NYSE •
Healthcare •
Medical Devices •
Quote as of 09/08/2026 12:05
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization1,246.7 mln
Float40.58 mln
Earnings Date10/29/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.67
Likely reliable
1-Year Forecast
42.15
Transformational upside
Relative Strength
15
/ 100
Significantly lagging
Debt / Equity
0.92
Moderate leverage
Pre-Tax Margin
0%
Break-even
Business Description
Artivion is a global medical company that develops and supplies a broad range of products designed to treat heart and vascular conditions, including artificial heart valves, stent graft systems, surgical sealants, and preserved human tissue. The company also offers specialized services such as tissue preservation and proprietary coating technologies used by surgeons during complex cardiovascular procedures. Founded in 1984 and based in Kennesaw, Georgia, Artivion sells its products directly to hospitals and healthcare facilities through its own sales team. Previously known as CryoLife, the company rebranded under its current name in January 2022.
